PLIN3 and prostate carcinoma: upregulation of ACSS3 in prostate cancer cells regulates PLIN3 stability, reduces lipid droplet deposition, and induces ER stress-mediated apoptosis, reversing enzalutamide resistance and hindering castration-resistant prostate cancer progression [47].